Publication: Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
dc.contributor.author | Rodger, Alison J | |
dc.contributor.author | Cambiano, Valentina | |
dc.contributor.author | Bruun, Tina | |
dc.contributor.author | Vernazza, Pietro | |
dc.contributor.author | Collins, Simon | |
dc.contributor.author | van Lunzen, Jan | |
dc.contributor.author | Corbelli, Giulio Maria | |
dc.contributor.author | Estrada, Vicente | |
dc.contributor.author | Geretti, Anna Maria | |
dc.contributor.author | Beloukas, Apostolos | |
dc.contributor.author | Asboe, David | |
dc.contributor.author | Viciana, Pompeyo | |
dc.contributor.author | Gutiérrez, Félix | |
dc.contributor.author | Clotet, Bonaventura | |
dc.contributor.author | Pradier, Christian | |
dc.contributor.author | Gerstoft, Jan | |
dc.contributor.author | Weber, Rainer | |
dc.contributor.author | Westling, Katarina | |
dc.contributor.author | Wandeler, Gilles | |
dc.contributor.author | Prins, Jan M | |
dc.contributor.author | Rieger, Armin | |
dc.contributor.author | Stoeckle, Marcel | |
dc.contributor.author | Kümmerle, Tim | |
dc.contributor.author | Bini, Teresa | |
dc.contributor.author | Ammassari, Adriana | |
dc.contributor.author | Gilson, Richard | |
dc.contributor.author | Krznaric, Ivanka | |
dc.contributor.author | Ristola, Matti | |
dc.contributor.author | Zangerle, Robert | |
dc.contributor.author | Handberg, Pia | |
dc.contributor.author | Antela, Antonio | |
dc.contributor.author | Allan, Sris | |
dc.contributor.author | Phillips, Andrew N | |
dc.contributor.author | Lundgren, Jens | |
dc.contributor.author | PARTNER Study Group | |
dc.date.accessioned | 2023-01-25T08:34:13Z | |
dc.date.available | 2023-01-25T08:34:13Z | |
dc.date.issued | 2016 | |
dc.description.abstract | A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through condomless sex with suppressed HIV-1 RNA viral load for both anal and vaginal sex. To evaluate the rate of within-couple HIV transmission (heterosexual and men who have sex with men [MSM]) during periods of sex without condoms and when the HIV-positive partner had HIV-1 RNA load less than 200 copies/mL. The prospective, observational PARTNER (Partners of People on ART-A New Evaluation of the Risks) study was conducted at 75 clinical sites in 14 European countries and enrolled 1166 HIV serodifferent couples (HIV-positive partner taking suppressive ART) who reported condomless sex (September 2010 to May 2014). Eligibility criteria for inclusion of couple-years of follow-up were condomless sex and HIV-1 RNA load less than 200 copies/mL. Anonymized phylogenetic analysis compared couples' HIV-1 polymerase and envelope sequences if an HIV-negative partner became infected to determine phylogenetically linked transmissions. Condomless sexual activity with an HIV-positive partner taking virally suppressive ART. Risk of within-couple HIV transmission to the HIV-negative partner. Among 1166 enrolled couples, 888 (mean age, 42 years [IQR, 35-48]; 548 heterosexual [61.7%] and 340 MSM [38.3%]) provided 1238 eligible couple-years of follow-up (median follow-up, 1.3 years [IQR, 0.8-2.0]). At baseline, couples reported condomless sex for a median of 2 years (IQR, 0.5-6.3). Condomless sex with other partners was reported by 108 HIV-negative MSM (33%) and 21 heterosexuals (4%). During follow-up, couples reported condomless sex a median of 37 times per year (IQR, 15-71), with MSM couples reporting approximately 22,000 condomless sex acts and heterosexuals approximately 36,000. Although 11 HIV-negative partners became HIV-positive (10 MSM; 1 heterosexual; 8 reported condomless sex with other partners), no phylogenetically linked transmissions occurred over eligible couple-years of follow-up, giving a rate of within-couple HIV transmission of zero, with an upper 95% confidence limit of 0.30/100 couple-years of follow-up. The upper 95% confidence limit for condomless anal sex was 0.71 per 100 couple-years of follow-up. Among serodifferent heterosexual and MSM couples in which the HIV-positive partner was using suppressive ART and who reported condomless sex, during median follow-up of 1.3 years per couple, there were no documented cases of within-couple HIV transmission (upper 95% confidence limit, 0.30/100 couple-years of follow-up). Additional longer-term follow-up is necessary to provide more precise estimates of risk. | |
dc.identifier.doi | 10.1001/jama.2016.5148 | |
dc.identifier.essn | 1538-3598 | |
dc.identifier.pmid | 27404185 | |
dc.identifier.unpaywallURL | https://jamanetwork.com/journals/jama/articlepdf/2533066/joi160044.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/10259 | |
dc.issue.number | 2 | |
dc.journal.title | JAMA | |
dc.journal.titleabbreviation | JAMA | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 171-81 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Multicenter Study | |
dc.pubmedtype | Observational Study | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights.accessRights | open access | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Anti-HIV Agents | |
dc.subject.mesh | Condoms | |
dc.subject.mesh | Europe | |
dc.subject.mesh | Family Characteristics | |
dc.subject.mesh | Female | |
dc.subject.mesh | HIV Infections | |
dc.subject.mesh | HIV Seronegativity | |
dc.subject.mesh | HIV Seropositivity | |
dc.subject.mesh | HIV-1 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Phylogeny | |
dc.subject.mesh | Prospective Studies | |
dc.subject.mesh | RNA, Viral | |
dc.subject.mesh | Risk | |
dc.subject.mesh | Sexual Behavior | |
dc.subject.mesh | Sexual Partners | |
dc.subject.mesh | Unsafe Sex | |
dc.subject.mesh | Viral Load | |
dc.title | Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 316 | |
dspace.entity.type | Publication |